Tay Therapeutics, a University of Dundee spinout, has agreed a licensing deal with US biotech VYNE Therapeutics focused on developing therapies for immuno-inflammatory diseases. Click to read more.
MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative diseases, announces the close of its seed financing. Financial details are not disclosed .